Murcko scaffold
Ring system with 6 rings and 19 atoms
48 chemicals on CompoundList share this ring system.
- Rings
- 6
- Scaffold atoms
- 19
- Chemicals
- 48
- With full pages
- 5
Scaffold SMILES
O=C(CC12CC3CC(CC(C3)C1)C2)N1CCC2CC21
A Bemis-Murcko scaffold is what remains of a molecule when every side chain is removed: the rings and the chains that link them. Chemicals that share a scaffold often belong to the same compound series, which helps when you look for analogues, alternative suppliers or related building blocks.
Computed from the structures of the chemicals listed here. Stereo and charges are removed before the scaffold is taken.
Chemicals with this scaffold
Open one to see its structure, properties and suppliers.
Showing 1 to 48 of 48 chemicals
3-Deoxy saxagliptin
CAS 361441-98-7C18H25N3O
Saxagliptin
CAS 361442-04-8C18H25N3O2
3-[(1S)-2-[(1S,3S,5S)-3-Cyano-2-azabicyclo[3.1.0]hex-2-yl]-2-oxo-1-[(2,2,2-trifluoroacetyl)amino]ethyl]tricyclo[3.3.1.13,7]dec-1-yl 2,2,2-trifluoroacetate
CAS 865999-68-4C22H23F6N3O4
(1S,3S,5S)-2-((2S)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile 2,2,2-trifluoroacetate (1:1)
CAS 361442-05-9C20H26F3N3O4
(1S,3S,5S)-2-((2S)-2-Amino-2-(3,5-dihydroxyadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile 2,2,2-trifluoroacetate(1:1)
CAS 841302-57-6C20H26F3N3O5
(1S,3S,5S)-2-((2S)-2-Amino-2-(3,5-dihydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile
CAS 841302-24-7C18H25N3O3
(2'S,2R,cis)-Saxagliptin
CAS 1564265-94-6C18H25N3O2
Saxagliptin hydrochloride
CAS 709031-78-7C18H26ClN3O2
Boc-saxagliptin
CAS 709031-43-6C23H33N3O4
Saxagliptin hydrate
CAS 945667-22-1C18H27N3O3
1,1-Dimethylethyl N-[(1S)-2-[(1S,3S,5S)-3-(aminocarbonyl)-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]carbamate
CAS 361442-01-5C23H35N3O5
Metformin hydrochloride, saxagliptin hydrochloride
CAS 1198772-17-6C22H36N8O2
Saxagliptin-13C3
CAS 1564265-98-0C18H25N3O2
(2'R,2S,cis)-Saxagliptin
CAS 1564265-93-5C18H25N3O2
(1R,3S,5R)-2-((S)-2-Amino-2-((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile
CAS 1564265-96-8C18H25N3O2
(1S,3R,5S)-2-[(2S)-2-Amino-2-[(5S,7R)-3-hydroxy-1-adamantyl]acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
CAS 1564266-00-7C18H25N3O2
3-Descarbonitrile 3-acetamido saxagliptin
CAS 1496712-39-0C18H27N3O3
(1S,3R,5S)-2-[(2S)-2-Amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
C18H25N3O2
(1R,3S,5R)-2-((2R)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile
C18H25N3O2
(2'R,2R,cis)-Saxagliptin
CAS 1564265-95-7C18H25N3O2
(2'R,2R,trans)-Saxagliptin
CAS 1564266-03-0C18H25N3O2
(2S,2S',trans)-Saxagliptin
C18H25N3O2
Saxagliptin benzoate hydrate
CAS 1073057-33-6C25H33N3O5
Saxagliptin hydrochloride dihydrate
CAS 1073057-20-1C18H30ClN3O4
- Saxagliptin tartrate hemihydrate1073057-37-0C44H64N6O17
- 2-Azabicyclo(3.1.0)hexane-3-carbonitrile, 2-((2S)-2-amino-2-(3-(sulfooxy)tricyclo(3.3.1.13,7)dec-1-yl)acetyl)-, (1S,3S,5S)-1429782-94-4C18H25N3O5S
- Saxagliptin-15N,D2 hydrochloride1309934-06-2C18H26ClN3O2
- 2 suppliers2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, hydrochloride, hydrate (1:1:2), (1S,3S,5S)-1370409-28-1C18H28ClN3O3
- (1R,3S,5R)-2-[(2R)-2-Amino-2-[(5S,7R)-3-hydroxy-1-adamantyl]acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrileC18H25N3O2
- [(5S,7R)-3-[(1S)-2-[(1S,3S,5S)-3-Cyano-2-azabicyclo[3.1.0]hexan-2-yl]-1-[(2-methylpropan-2-yl)oxycarbonylamino]-2-oxoethyl]-1-adamantyl] 2,2,2-trifluoroacetateC25H32F3N3O5
- (2S,2'R,cis)-7-Hydroxy-saxagliptin1795791-40-0C18H25N3O3
- Hydroxy saxagliptin-15N,D2 hydrochloride1309934-05-1C18H26ClN3O3
- Hydroxy saxagliptin-13C31346597-23-6C18H25N3O3
- BMS-538305 HCl841302-51-0C17H27ClN2O2
- (2S)-2-Amino-1-(2-azabicyclo[3.1.0]hexan-2-yl)-2-((1S,5R)-3-hydroxyadamantan-1-yl)ethan-1-one841302-20-3C17H26N2O2
- HydroxySaxagliptin-15N,D2HydrochlorideC18H26ClN3O3
- Saxagliptin N-trifluoroacetate865999-70-8C20H24F3N3O3
- (1S,3S,5S)-2-[2-Amino-2-[(5S,7R)-3-hydroxy-1-adamantyl]acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrileC18H25N3O2
- Saxagliptin-13C-D2 hydrochloride2699827-95-5C18H26ClN3O2
- (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carboxylic acid1802786-89-5C18H26N2O4
- (±)-Saxagliptin-13C3 (acetyl-13C2,cyclopropyl-3-13C)1246812-44-1C18H25N3O2
- Hydroxy saxagliptin-13C,D2 hydrochloride1572922-53-2C18H26ClN3O3
- Hydroxy saxagliptin-15N,D2 hydrochlorideC18H26ClN3O3
- (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carboxamide, hydrochloride2173146-02-4C18H28ClN3O3
- Saxagliptin impurity 30C22H23F6N3O4
- rel-(1R,3R,5R)-2-((2R)-2-Amino-2-(3,5-dihydroxyadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile1310011-46-1C18H25N3O3
- Saxagliptin impurity 891194836-75-3C25H32F3N3O5
- Saxagliptin impurity 931642872-42-1C22H34N2O3